Cabazitaxel

On The Horizon – A Status Report of Six New Promising Advancing Treatments for Men with Advanced Prostate Cancer as of the Beginning of June, 2010

As of today there are many different potential drugs undergoing phase III evaluations for men with advanced prostate cancer, some of them seem to offer great hope and promise. Considering we just had Provenge finally approved, this is great news. […]

By |2010-06-08T09:15:34-04:00June 8th, 2010|abiraterone acetate, Advanced Prostate Cancer, Alpharadin (radium-223), Cabazitaxel, Chemo Therapy, Clinical Trials, Clinical Trials, Drugs & Treatments, FDA, General Information, Hormone Therapy, MDV3100, On The Horizon, Prostate Ponderings, Prostvac, Research, TAK700, Uncategorized, Understanding APC|3 Comments
Read More

On The Horizon – Cabazitaxel Extends Life After Chemotherapy Failure

The drug is called Cabazitaxel, (it will be named Jevtana) and is made by the French company Sanofi-Aventis SA. Cabazitaxel is a chemical cousin of Taxotere (the current standard of care) and it is designed to evade the mechanism that cancer cells use to resist Taxotere, so we can assume that initially it would be [...]

By |2010-03-05T13:20:26-05:00March 5th, 2010|Advanced Prostate Cancer, Cabazitaxel, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Drugs & Treatments, End-Of-Life, On The Horizon, Uncategorized, Understanding APC|1 Comment
Read More
Go to Top